Cargando…

Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey

BACKGROUND: Pseudomonas aeruginosa is the third most common pathogen responsible for nosocomial infections and the prevalence of multiple resistant isolates has been increasing. Ninety-nine clinical isolates were studied in order to assess the current levels of susceptibility and cross-resistances o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gençer, Serap, Ak, Öznur, Benzonana, Nur, Batırel, Ayşe, Özer, Serdar
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149377/
https://www.ncbi.nlm.nih.gov/pubmed/12437779
http://dx.doi.org/10.1186/1476-0711-1-2
_version_ 1782120623922741248
author Gençer, Serap
Ak, Öznur
Benzonana, Nur
Batırel, Ayşe
Özer, Serdar
author_facet Gençer, Serap
Ak, Öznur
Benzonana, Nur
Batırel, Ayşe
Özer, Serdar
author_sort Gençer, Serap
collection PubMed
description BACKGROUND: Pseudomonas aeruginosa is the third most common pathogen responsible for nosocomial infections and the prevalence of multiple resistant isolates has been increasing. Ninety-nine clinical isolates were studied in order to assess the current levels of susceptibility and cross-resistances of widely used antipseudomonal antibiotics against P. aeruginosa and to determine some resistance mechanisms by phenotypic methods. METHODS: MICs of isolates for nine antipseudomonal antibiotics were determined by the E test method. RESULTS: Thirty-six percent of isolates were resistant to more than one group of antibiotics. The rates of susceptible isolates were ciprofloxacin 75%, amikacin 73%, ceftazidime 65%, meropenem 63%, imipenem 63%, piperacillin/tazobactam 60%, cefoperazone/sulbactam 59%, cefepime 54% and tobramycin 44%. The majority of carbapenem resistant isolates were susceptible to ciprofloxacin and amikacin. CONCLUSION: Ciprofloxacin seems to be the most active agent against P. aeruginosa followed by amikacin in our unit. The usefulness of combinations of these antibiotics and β-lactams should be tested in treating multi-drug resistant P. aeruginosa.
format Text
id pubmed-149377
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1493772003-02-25 Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey Gençer, Serap Ak, Öznur Benzonana, Nur Batırel, Ayşe Özer, Serdar Ann Clin Microbiol Antimicrob Research BACKGROUND: Pseudomonas aeruginosa is the third most common pathogen responsible for nosocomial infections and the prevalence of multiple resistant isolates has been increasing. Ninety-nine clinical isolates were studied in order to assess the current levels of susceptibility and cross-resistances of widely used antipseudomonal antibiotics against P. aeruginosa and to determine some resistance mechanisms by phenotypic methods. METHODS: MICs of isolates for nine antipseudomonal antibiotics were determined by the E test method. RESULTS: Thirty-six percent of isolates were resistant to more than one group of antibiotics. The rates of susceptible isolates were ciprofloxacin 75%, amikacin 73%, ceftazidime 65%, meropenem 63%, imipenem 63%, piperacillin/tazobactam 60%, cefoperazone/sulbactam 59%, cefepime 54% and tobramycin 44%. The majority of carbapenem resistant isolates were susceptible to ciprofloxacin and amikacin. CONCLUSION: Ciprofloxacin seems to be the most active agent against P. aeruginosa followed by amikacin in our unit. The usefulness of combinations of these antibiotics and β-lactams should be tested in treating multi-drug resistant P. aeruginosa. BioMed Central 2002-10-09 /pmc/articles/PMC149377/ /pubmed/12437779 http://dx.doi.org/10.1186/1476-0711-1-2 Text en Copyright © 2002 Gençer et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research
Gençer, Serap
Ak, Öznur
Benzonana, Nur
Batırel, Ayşe
Özer, Serdar
Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey
title Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey
title_full Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey
title_fullStr Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey
title_full_unstemmed Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey
title_short Susceptibility patterns and cross resistances of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey
title_sort susceptibility patterns and cross resistances of antibiotics against pseudomonas aeruginosa in a teaching hospital of turkey
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149377/
https://www.ncbi.nlm.nih.gov/pubmed/12437779
http://dx.doi.org/10.1186/1476-0711-1-2
work_keys_str_mv AT gencerserap susceptibilitypatternsandcrossresistancesofantibioticsagainstpseudomonasaeruginosainateachinghospitalofturkey
AT akoznur susceptibilitypatternsandcrossresistancesofantibioticsagainstpseudomonasaeruginosainateachinghospitalofturkey
AT benzonananur susceptibilitypatternsandcrossresistancesofantibioticsagainstpseudomonasaeruginosainateachinghospitalofturkey
AT batırelayse susceptibilitypatternsandcrossresistancesofantibioticsagainstpseudomonasaeruginosainateachinghospitalofturkey
AT ozerserdar susceptibilitypatternsandcrossresistancesofantibioticsagainstpseudomonasaeruginosainateachinghospitalofturkey